Madrigal Pharmaceuticals logo
Madrigal Pharmaceuticals MDGL
$ 346.39 5.21%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Madrigal Pharmaceuticals Balance Sheet 2011-2024 | MDGL

Annual Balance Sheet Madrigal Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

16.1 M -282 M -35.5 M - -46 M -57.4 M -149 M -19.1 M -30.3 M -32.2 M -25.2 M -69.1 M -13.5 M

Long Term Debt

115 M 49.3 M 387 K - - - - - - 4.61 M 13.8 M 4.46 M 12.4 M

Long Term Debt Current

527 K 602 K 410 K 318 K 315 K - - - - - - - -

Total Non Current Liabilities

117 M 49.3 M 387 K 468 K 361 K - - - - 4.65 M 13.9 M 4.46 M 12.4 M

Total Current Liabilities

119 M 116 M 76.8 M 46.6 M 25.1 M 8.44 M 10.1 M 4.8 M 49.3 M 30.9 M 32.2 M 23.5 M 15.1 M

Total Liabilities

235 M 165 M 77.2 M 47 M 25.5 M 8.44 M 10.1 M 4.8 M 17.8 M 35.5 M 46.1 M 28 M 27.6 M

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

-1.34 B -963 M -667 M -425 M -223 M -139 M -106 M -75.3 M -706 M -638 M -551 M -461 M -398 M

Total Assets

641 M 363 M 273 M 287 M 442 M 485 M 192 M 41.2 M 68.2 M 101 M 95.2 M 103 M 42.3 M

Cash and Cash Equivalents

99.9 M 332 M 36.3 M 54 M 46.7 M 57.4 M 149 M 19.1 M 306 K 148 K 48.5 M 81.5 M 30.1 M

Book Value

405 M 197 M 196 M 240 M 417 M 477 M 182 M 36.4 M 50.4 M 65.1 M 49.1 M 75.1 M 14.8 M

Total Shareholders Equity

405 M 197 M 196 M 240 M 417 M 477 M 182 M 36.4 M -48.9 M 65.1 M 49.1 M 75.1 M 14.8 M

All numbers in USD currency

Quarterly Balance Sheet Madrigal Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

117 M 117 M 116 M 115 M 115 M 99.2 M 84 M 49.3 M 49 M - 283 K 387 K 491 K 594 K 387 K 468 K 468 K 468 K 468 K 361 K 361 K 361 K 361 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

118 M 118 M 117 M 117 M 116 M 99.2 M 84 M 49.3 M 49.1 M - 283 K 387 K 491 K 594 K 387 K 468 K 468 K 468 K 468 K 361 K 361 K 361 K 361 K - - - - - - - - - - - - - 11 K 32 K 2.33 M 4.65 M 4.65 M 4.65 M 4.65 M 13.9 M 13.9 M 13.9 M 13.9 M 4.46 M 4.46 M 4.46 M 4.46 M 12.4 M 12.4 M 12.4 M 12.4 M

Total Liabilities

296 M 243 M 232 M 235 M 216 M 199 M 182 M 165 M 148 M - 76.9 M 77.2 M 69.8 M 57.3 M 49.2 M 47 M 47 M 47 M 47 M 25.5 M 25.5 M 25.5 M 25.5 M 8.44 M 8.44 M 8.44 M 8.44 M 10.1 M 10.1 M 10.1 M 10.1 M 4.8 M 4.8 M 4.8 M 4.8 M 49.3 M 49.3 M 17.8 M 17.8 M 35.5 M 35.5 M 35.5 M 35.5 M 46.1 M 46.1 M 46.1 M 46.1 M 28 M 28 M 28 M 28 M 27.6 M 27.6 M 27.6 M 27.6 M

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3.3 M 4.45 M -

Retained Earnings

-1.74 B -1.64 B -1.48 B -1.34 B -1.22 B -1.13 B -1.04 B -963 M -877 M - -725 M -667 M -603 M -540 M -478 M -425 M -425 M -425 M -425 M -223 M -223 M -223 M -223 M -139 M -139 M -139 M -139 M -106 M -106 M -106 M -106 M -75.3 M -75.3 M -75.3 M -75.3 M -48.9 M -48.9 M -706 M -706 M -638 M -638 M -638 M -638 M -551 M -551 M -551 M -551 M -461 M -461 M -461 M -461 M -398 M -398 M -398 M -398 M

Total Assets

1.07 B 1.1 B 1.08 B 641 M 238 M 302 M 332 M 363 M 159 M - 223 M 273 M 305 M 328 M 310 M 287 M 287 M 287 M 287 M 442 M 442 M 442 M 442 M 485 M 485 M 485 M 485 M 192 M 192 M 192 M 192 M 41.2 M 41.2 M 41.2 M 41.2 M 364 K 364 K 68.2 M 68.2 M 101 M 101 M 101 M 101 M 95.2 M 95.2 M 95.2 M 95.2 M 103 M 103 M 103 M 103 M 42.3 M 42.3 M 42.3 M 42.3 M

Cash and Cash Equivalents

233 M 495 M 623 M 99.9 M 62.1 M 77.2 M 113 M 332 M 59.3 M 53.3 M 42.3 M 36.3 M 49.2 M 33.5 M 44.2 M 54 M 54 M 54 M 54 M 46.7 M 46.7 M 46.7 M 46.7 M 57.4 M 57.4 M 57.4 M 57.4 M 149 M 149 M 149 M 149 M 19.1 M 19.1 M 19.1 M 19.1 M 306 K 306 K 35 M 35 M 148 K 46 M 46 M 46 M 48.5 M 48.5 M 48.5 M 48.5 M 81.5 M 81.5 M 81.5 M 81.5 M 30.1 M 30.1 M 30.1 M 30.1 M

Book Value

777 M 857 M 851 M 405 M 22.2 M 104 M 150 M 197 M 10.7 M - 146 M 196 M 235 M 271 M 261 M 240 M 240 M 240 M 240 M 417 M 417 M 417 M 417 M 477 M 477 M 477 M 477 M 182 M 182 M 182 M 182 M 36.4 M 36.4 M 36.4 M 36.4 M -48.9 M -48.9 M 50.4 M 50.4 M 65.1 M 65.1 M 65.1 M 65.1 M 49.1 M 49.1 M 49.1 M 49.1 M 75.1 M 75.1 M 75.1 M 75.1 M 14.8 M 14.8 M 14.8 M 14.8 M

Total Shareholders Equity

777 M 857 M 851 M 405 M 22.2 M 104 M 150 M 197 M 10.7 M 83.5 M 146 M 196 M 235 M 271 M 261 M 240 M 240 M 240 M 240 M 417 M 417 M 417 M 417 M 477 M 477 M 477 M 477 M 182 M 182 M 182 M 182 M 36.4 M 36.4 M 36.4 M 36.4 M -48.9 M -48.9 M 50.4 M 50.4 M -42.1 M 65.1 M 65.1 M 65.1 M 49.1 M 49.1 M 49.1 M 49.1 M 75.1 M 75.1 M 75.1 M 75.1 M 14.8 M 14.8 M 14.8 M 14.8 M

All numbers in USD currency